SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge.

Schafer, CM; Martin-Almedina, S; Kurylowicz, K; Dufton, N; Osuna-Almagro, L; Wu, M-L; Johnson, CF; Shah, AV; Haskard, DO; Buxton, A; et al. Schafer, CM; Martin-Almedina, S; Kurylowicz, K; Dufton, N; Osuna-Almagro, L; Wu, M-L; Johnson, CF; Shah, AV; Haskard, DO; Buxton, A; Willis, E; Wheeler, K; Turner, S; Chlebicz, M; Scott, RP; Kovats, S; Cleuren, A; Birdsey, GM; Randi, AM; Griffin, CT (2023) Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge. Arterioscler Thromb Vasc Biol, 43 (8). pp. 1412-1428. ISSN 1524-4636 https://doi.org/10.1161/ATVBAHA.123.318926
SGUL Authors: Martin Almedina, Silvia

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB) | Preview
[img]
Preview
PDF (Supplemental data 1) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (78MB) | Preview
[img]
Preview
PDF (Supplemental data 2) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (3MB) | Preview

Abstract

BACKGROUND: During infectious diseases, proinflammatory cytokines transiently destabilize interactions between adjacent vascular endothelial cells (ECs) to facilitate the passage of immune molecules and cells into tissues. However, in the lung, the resulting vascular hyperpermeability can lead to organ dysfunction. Previous work identified the transcription factor ERG (erythroblast transformation-specific-related gene) as a master regulator of endothelial homeostasis. Here we investigate whether the sensitivity of pulmonary blood vessels to cytokine-induced destabilization is due to organotypic mechanisms affecting the ability of endothelial ERG to protect lung ECs from inflammatory injury. METHODS: Cytokine-dependent ubiquitination and proteasomal degradation of ERG were analyzed in cultured HUVECs (human umbilical vein ECs). Systemic administration of TNFα (tumor necrosis factor alpha) or the bacterial cell wall component lipopolysaccharide was used to cause a widespread inflammatory challenge in mice; ERG protein levels were assessed by immunoprecipitation, immunoblot, and immunofluorescence. Murine Erg deletion was genetically induced in ECs (Ergfl/fl;Cdh5[PAC]-CreERT2), and multiple organs were analyzed by histology, immunostaining, and electron microscopy. RESULTS: In vitro, TNFα promoted the ubiquitination and degradation of ERG in HUVECs, which was blocked by the proteasomal inhibitor MG132. In vivo, systemic administration of TNFα or lipopolysaccharide resulted in a rapid and substantial degradation of ERG within lung ECs but not ECs of the retina, heart, liver, or kidney. Pulmonary ERG was also downregulated in a murine model of influenza infection. Ergfl/fl;Cdh5(PAC)-CreERT2 mice spontaneously recapitulated aspects of inflammatory challenges, including lung-predominant vascular hyperpermeability, immune cell recruitment, and fibrosis. These phenotypes were associated with a lung-specific decrease in the expression of Tek-a gene target of ERG previously implicated in maintaining pulmonary vascular stability during inflammation. CONCLUSIONS: Collectively, our data highlight a unique role for ERG in pulmonary vascular function. We propose that cytokine-induced ERG degradation and subsequent transcriptional changes in lung ECs play critical roles in the destabilization of pulmonary blood vessels during infectious diseases.

Item Type: Article
Additional Information: © 2023 The Authors. Arteriosclerosis, Thrombosis, and Vascular Biology is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
Keywords: capillary permeability, endothelial cells, inflammation, lung, proteolysis, transcription factors, Humans, Mice, Animals, Transcription Factors, Tumor Necrosis Factor-alpha, Lipopolysaccharides, Human Umbilical Vein Endothelial Cells, Cytokines, Communicable Diseases, Cells, Cultured, Transcriptional Regulator ERG, Cells, Cultured, Animals, Humans, Mice, Communicable Diseases, Lipopolysaccharides, Tumor Necrosis Factor-alpha, Transcription Factors, Cytokines, Human Umbilical Vein Endothelial Cells, Transcriptional Regulator ERG, capillary permeability, endothelial cells, inflammation, lung, proteolysis, transcription factors, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, Cardiovascular System & Hematology
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Arterioscler Thromb Vasc Biol
ISSN: 1524-4636
Language: eng
Dates:
DateEvent
August 2023Published
15 June 2023Published Online
31 May 2023Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
R01 HL119501NHLBI NIH HHSUNSPECIFIED
R35 HL144605NHLBI NIH HHSUNSPECIFIED
PG/10/94/28651British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
RG/11/17/29256British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
RG/17/4/32662British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
CA-831087American Lung Associationhttp://dx.doi.org/10.13039/100002590
UNSPECIFIEDOklahoma Medical Research Foundationhttp://dx.doi.org/10.13039/100008907
PubMed ID: 37317853
Web of Science ID: WOS:001037720700012
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115743
Publisher's version: https://doi.org/10.1161/ATVBAHA.123.318926

Actions (login required)

Edit Item Edit Item